Epcoritamab,Lenalidomide,Rituximab,cyclophosphamide,doxorubicin,vincristine,prednisone,bendamustine,cytarabine,dexamethasone,oxaliplatin,carboplatin,gemcitabine,ifosfamide
Genmab,Abbvie,Biogen,Roche
['lymsm', 'epcoritamab']
rounding out bispecifics in fl at #17icml, david belada sharing data on epcoritamab +r^2 time limited therapy; impressively high activity across high risk groups including pod24! early and durable remissions among responders with similar tox to prior reports #lymsm 
Heme/Onc fellow @UCCancerCenter interested in aggressive lymphoma, novel therapeutics, and cellular therapies #lymsm #TcellRx. Views are my own.